20th Annual World Congress on Anti-Aging & Regenerative Biomedical Technologies Attracts 3,000 Attendees
The Winter Session of the 20th Annual World Congress on Anti-Aging & Regenerative Biomedical Technologies drew 3,000 delegates and corporate leaders to an educational program featuring more than 100 speakers, who presented the latest scientific data on advanced preventive medical diagnostics and therapeutics, as well as emerging biomedical technologies.
The show, produced by U.K.-based Tarsus Group, was held in December at the Sands Expo & Convention Center in Las Vegas.
”The physicians and scientists involved in anti-aging science have been the first to embrace innovative medical discoveries and technological advancements that have subsequently been mainstreamed,” said Ronald Klatz, MD, DO, A4M president.
He added, “At The American Academy of Anti-Aging Medicine (A4M)’s World Congresses held continuously since 1993, over 100,000 physicians, health practitioners, and scientists have been among the first to learn of revolutionary life-enhancing, life-extending discoveries such as: the hormone melatonin as a cancer-fighting agent; the importance of growth hormone in adulthood; the identification of homocysteine as a marker for heart disease; the role of Vitamin D beyond bone health; advanced biomedical technologies including nanotechnology, DNA on a chip, and brain resuscitation; regenerative medical therapeutics such as stem cell therapies; and much more.”
The Annual World Congress on Anti-Aging & Regenerative Biomedical Technologies is recognized around the world for the high caliber of speakers, delegates and international government officials in attendance, according to event organizers.
More than 100 speakers, many of whom are leaders in their area of specialization, spoke on a broad array of topics in aging intervention.
“Since its founding in 1992, the A4M has been one of the fastest-growing medical societies in the world, starting with just twelve doctors to become an international, member-based professional scientific medical society of 26,000-plus physicians, health practitioners, and scientists,” said Robert Goldman, MD, PhD, DO, FAASP, A4M chairman.
He added, “Now in its third decade of educational service, the A4M’s scientific educational programs have trained over 100,000 medical professionals, and the organization’s education and advocacy initiatives have expanded the availability of advanced biotechnologies and leading-edge preventive healthcare throughout the world.”
The A4M Winter 2012 Congress commemorated the Platinum Anniversary of the founding of The American Academy of Anti-Aging Medicine, the world’s largest professional medical society dedicated to advancing research and clinical pursuits that enhance the quality, and extend the quantity, of the human lifespan.